{"id":8215,"date":"2025-04-15T12:11:07","date_gmt":"2025-04-15T04:11:07","guid":{"rendered":"https:\/\/regask.com\/?p=8215"},"modified":"2025-04-15T12:11:07","modified_gmt":"2025-04-15T04:11:07","slug":"regask-est-presente-dans-un-article-sur-les-tarifs-douaniers-chinois-et-les-soins-de-sante-americains","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","title":{"rendered":"RegASK pr\u00e9sent\u00e9 dans Healthcare Brew : Comment les tarifs sur Chin\u2026"},"content":{"rendered":"

Nous sommes fiers de partager cela RegASK a \u00e9t\u00e9 pr\u00e9sent\u00e9 dans Bi\u00e8re de soins de sant\u00e9<\/a><\/strong>Le dernier article de, \u00ab Comment les tarifs douaniers impos\u00e9s \u00e0 la Chine pourraient avoir un impact sur les soins de sant\u00e9 aux \u00c9tats-Unis. \u00bb<\/em> L\u2019article explore comment les nouveaux tarifs sur les ingr\u00e9dients pharmaceutiques chinois pourraient faire grimper les prix des m\u00e9dicaments, limiter l\u2019innovation et mettre \u00e0 rude \u00e9preuve les syst\u00e8mes de sant\u00e9 publique.<\/p>\n

PDG de RegASK Caroline Shleifer<\/strong> explique les effets potentiels en aval de ces tarifs, mettant en garde contre augmentation des co\u00fbts des m\u00e9dicaments<\/strong>, p\u00e9nuries potentielles<\/strong>, et r\u00e9duction des investissements en R&D<\/strong>Ses observations soulignent l\u2019urgence pour les organismes de r\u00e9glementation, les prestataires de soins de sant\u00e9 et les soci\u00e9t\u00e9s pharmaceutiques de surveiller les changements de politique mondiale qui peuvent perturber consid\u00e9rablement l\u2019acc\u00e8s aux m\u00e9dicaments essentiels.<\/p>\n

\ud83d\udd17 Lisez l'article complet ici : Healthcare Brew \u2013 Comment les tarifs douaniers impos\u00e9s \u00e0 la Chine pourraient impacter les soins de sant\u00e9 aux \u00c9tats-Unis<\/a><\/p>\n

Pour plus d'informations sur la mani\u00e8re dont les changements de politique, tels que les tarifs douaniers, remod\u00e8lent l'industrie pharmaceutique, lisez Article de RegASK dans Bloomberg.<\/strong><\/a><\/p>\n

Chez RegASK, nous nous engageons \u00e0 fournir des informations pr\u00e9cises et exploitables pour aider les \u00e9quipes r\u00e9glementaires \u00e0 naviguer en toute confiance dans le paysage de conformit\u00e9 en constante \u00e9volution d'aujourd'hui.<\/p>","protected":false},"excerpt":{"rendered":"

Nous sommes fiers d'annoncer que RegASK a \u00e9t\u00e9 mentionn\u00e9e dans le dernier article de Healthcare Brew, intitul\u00e9 \u201c\u00a0Comment les droits de douane sur les produits chinois pourraient impacter le syst\u00e8me de sant\u00e9 am\u00e9ricain\u00a0\u201d. Cet article examine comment les nouveaux droits de douane sur les ingr\u00e9dients pharmaceutiques chinois pourraient faire grimper le prix des m\u00e9dicaments, freiner l'innovation et mettre \u00e0 rude \u00e9preuve le syst\u00e8me de sant\u00e9 publique. Caroline Shleifer, PDG de RegASK, explique les r\u00e9percussions potentielles de ces mesures\u2026<\/p>","protected":false},"author":22,"featured_media":8216,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[528],"tags":[],"class_list":["post-8215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"acf":[],"yoast_head":"\nRegASK in Healthcare Brew: Impact of China Tariffs on US Pharma<\/title>\n<meta name=\"description\" content=\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/regask-est-presente-dans-un-article-sur-les-tarifs-douaniers-chinois-et-les-soins-de-sante-americains\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"RegASK featured in Healthcare Brew: How tariffs on China could impact US healthcare\" \/>\n<meta property=\"og:description\" content=\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/regask-est-presente-dans-un-article-sur-les-tarifs-douaniers-chinois-et-les-soins-de-sante-americains\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-15T04:11:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1201\" \/>\n\t<meta property=\"og:image:height\" content=\"900\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Divvya Behal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divvya Behal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"},\"author\":{\"name\":\"Divvya Behal\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\"},\"headline\":\"RegASK featured in Healthcare Brew: How tariffs on Chin…\",\"datePublished\":\"2025-04-15T04:11:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"},\"wordCount\":170,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"articleSection\":[\"Company News\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\",\"name\":\"RegASK in Healthcare Brew: Impact of China Tariffs on US Pharma\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"datePublished\":\"2025-04-15T04:11:07+00:00\",\"description\":\"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/regask-featured-healthcare-brew.jpg\",\"width\":1201,\"height\":900,\"caption\":\"Regask Featured Healthcare Brew\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\",\"name\":\"Divvya Behal\",\"sameAs\":[\"https:\\\/\\\/regask.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"RegASK dans Healthcare Brew\u00a0: Impact des droits de douane chinois sur les produits pharmaceutiques am\u00e9ricains","description":"Le PDG de RegASK partage ses r\u00e9flexions d'experts dans Healthcare Brew sur la mani\u00e8re dont les tarifs douaniers chinois pourraient perturber l'acc\u00e8s aux soins de sant\u00e9 et l'innovation aux \u00c9tats-Unis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/regask-est-presente-dans-un-article-sur-les-tarifs-douaniers-chinois-et-les-soins-de-sante-americains\/","og_locale":"fr_FR","og_type":"article","og_title":"RegASK featured in Healthcare Brew: How tariffs on China could impact US healthcare","og_description":"RegASK CEO shares expert insights in Healthcare Brew on how China tariffs could disrupt US healthcare access and innovation.","og_url":"https:\/\/regask.com\/fr\/regask-est-presente-dans-un-article-sur-les-tarifs-douaniers-chinois-et-les-soins-de-sante-americains\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2025-04-15T04:11:07+00:00","og_image":[{"width":1201,"height":900,"url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","type":"image\/jpeg"}],"author":"Divvya Behal","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Divvya Behal","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#article","isPartOf":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"},"author":{"name":"Divvya Behal","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0"},"headline":"RegASK featured in Healthcare Brew: How tariffs on Chin…","datePublished":"2025-04-15T04:11:07+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"},"wordCount":170,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","articleSection":["Company News"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","url":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/","name":"RegASK dans Healthcare Brew\u00a0: Impact des droits de douane chinois sur les produits pharmaceutiques am\u00e9ricains","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","datePublished":"2025-04-15T04:11:07+00:00","description":"Le PDG de RegASK partage ses r\u00e9flexions d'experts dans Healthcare Brew sur la mani\u00e8re dont les tarifs douaniers chinois pourraient perturber l'acc\u00e8s aux soins de sant\u00e9 et l'innovation aux \u00c9tats-Unis.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/regask-featured-in-healthcare-brew-on-china-tariffs-and-us-healthcare\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2025\/04\/regask-featured-healthcare-brew.jpg","width":1201,"height":900,"caption":"Regask Featured Healthcare Brew"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d'exploitation d'IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0","name":"Divvya Behal","sameAs":["https:\/\/regask.com"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/8215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=8215"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/8215\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/8216"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=8215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=8215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=8215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}